Status:
ACTIVE_NOT_RECRUITING
Reducing Opioid Prescription After Kidney Stone Removal Surgery
Lead Sponsor:
Mayo Clinic
Conditions:
Kidney Stone
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to implement and assess a standard way of prescribing opioid pain medication following PCNL (a kidney stone removal surgery) to ensure patients are being discharged with a...
Detailed Description
Participants in this study will have their opioid pain medication prescription at discharge following PCNL (Percutaneous Nephrolithotomy, a kidney stone removal surgery) determined by an algorithm in ...
Eligibility Criteria
Inclusion
- \- Patients undergoing percutaneous nephrolithotomy at Mayo Clinic Rochester.
Exclusion
- Unable or unwilling to provide informed consent.
- Patients who require Intensive Care Unit admission after surgery.
- Patients who have Clavien grade III or greater postoperative complications requiring additional intervention \< 30 days after index procedure.
Key Trial Info
Start Date :
June 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05353478
Start Date
June 6 2022
End Date
August 1 2026
Last Update
August 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905